Daan Gene Co., Ltd. (SHE:002030)

China flag China · Delayed Price · Currency is CNY
6.33
+0.02 (0.32%)
Jan 23, 2026, 11:30 AM CST
14.26%
Market Cap8.86B
Revenue (ttm)765.48M
Net Income (ttm)-563.95M
Shares Out1.40B
EPS (ttm)-0.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,854,700
Average Volume19,293,029
Open6.40
Previous Close6.31
Day's Range6.29 - 6.40
52-Week Range5.11 - 7.77
Beta0.34
RSI51.85
Earnings DateApr 3, 2026

About Daan Gene

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, publi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 1,730
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002030
Full Company Profile

Financial Performance

Financial Statements